Intuitive Surgical (NASDAQ:ISRG) Announces Quarterly Earnings Results, Beats Expectations By $0.27 EPS

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) posted its quarterly earnings data on Tuesday. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.92 by $0.27, RTT News reports. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company's revenue was up 21.4% compared to the same quarter last year. During the same period last year, the company earned $1.78 EPS.

Intuitive Surgical Trading Down 1.0%

Shares of Intuitive Surgical stock traded down $5.12 during trading on Tuesday, hitting $511.00. The stock had a trading volume of 2,403,865 shares, compared to its average volume of 1,665,577. The firm has a market cap of $183.15 billion, a price-to-earnings ratio of 74.93, a P/E/G ratio of 5.50 and a beta of 1.64. The business's 50-day moving average is $535.90 and its 200 day moving average is $536.29. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00.

Wall Street Analyst Weigh In

A number of research firms recently commented on ISRG. Evercore ISI upped their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Robert W. Baird reduced their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $566.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, July 14th. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $592.86.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president directly owned 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Intuitive Surgical

An institutional investor recently raised its position in Intuitive Surgical stock. Brighton Jones LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,672 shares of the medical equipment provider's stock after purchasing an additional 731 shares during the quarter. Brighton Jones LLC's holdings in Intuitive Surgical were worth $1,916,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.